169 related articles for article (PubMed ID: 14990687)
1. Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.
Haddad A; Nokhbeh MR; Alexander DA; Dawe SJ; Grisé C; Gulzar N; Dimock K
J Virol; 2004 Mar; 78(6):2674-81. PubMed ID: 14990687
[TBL] [Abstract][Full Text] [Related]
2. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).
Karnauchow TM; Tolson DL; Harrison BA; Altman E; Lublin DM; Dimock K
J Virol; 1996 Aug; 70(8):5143-52. PubMed ID: 8764022
[TBL] [Abstract][Full Text] [Related]
3. Sialic acid functions in enterovirus 70 binding and infection.
Alexander DA; Dimock K
J Virol; 2002 Nov; 76(22):11265-72. PubMed ID: 12388686
[TBL] [Abstract][Full Text] [Related]
4. Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.
Newcombe NG; Johansson ES; Au G; Lindberg AM; Barry RD; Shafren DR
J Virol; 2004 Feb; 78(3):1431-9. PubMed ID: 14722298
[TBL] [Abstract][Full Text] [Related]
5. Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines.
Nokhbeh MR; Hazra S; Alexander DA; Khan A; McAllister M; Suuronen EJ; Griffith M; Dimock K
J Virol; 2005 Jun; 79(11):7087-94. PubMed ID: 15890948
[TBL] [Abstract][Full Text] [Related]
6. Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.
Karnauchow TM; Dawe S; Lublin DM; Dimock K
J Virol; 1998 Nov; 72(11):9380-3. PubMed ID: 9765493
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity.
Kim MS; Racaniello VR
J Virol; 2007 Aug; 81(16):8648-55. PubMed ID: 17537857
[TBL] [Abstract][Full Text] [Related]
8. Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells.
Shieh JT; Bergelson JM
J Virol; 2002 Sep; 76(18):9474-80. PubMed ID: 12186929
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.
Shafren DR; Dorahy DJ; Ingham RA; Burns GF; Barry RD
J Virol; 1997 Jun; 71(6):4736-43. PubMed ID: 9151867
[TBL] [Abstract][Full Text] [Related]
10. Characterization of infections of human leukocytes by non-polio enteroviruses.
Hwang JY; Jun EJ; Seo I; Won M; Ahn J; Kim YK; Lee H
Intervirology; 2012; 55(5):333-41. PubMed ID: 22057046
[TBL] [Abstract][Full Text] [Related]
11. Towards an in vitro model for acute hemorrhagic conjunctivitis: cytokine-mediated vascular endothelial cell activation triggered by enterovirus type 70 infection.
Chang CH; Lin KH; Anderson R
J Clin Virol; 2004 May; 30(1):19-23. PubMed ID: 15072749
[TBL] [Abstract][Full Text] [Related]
12. Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.
Spiller OB; Goodfellow IG; Evans DJ; Hinchliffe SJ; Morgan BP
J Gen Virol; 2002 Jan; 83(Pt 1):45-52. PubMed ID: 11752699
[TBL] [Abstract][Full Text] [Related]
13. Enterovirus receptors and virus replication in human leukocytes.
Vuorinen T; Vainionp R; Heino J; Hyypi T
J Gen Virol; 1999 Apr; 80 ( Pt 4)():921-927. PubMed ID: 10211961
[TBL] [Abstract][Full Text] [Related]
14. Interactions of decay-accelerating factor (DAF) with haemagglutinating human enteroviruses: utilizing variation in primate DAF to map virus binding sites.
Williams DT; Chaudhry Y; Goodfellow IG; Lea S; Evans DJ
J Gen Virol; 2004 Mar; 85(Pt 3):731-738. PubMed ID: 14993659
[TBL] [Abstract][Full Text] [Related]
15. Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: implications for pathogenesis.
Smura T; Ylipaasto P; Klemola P; Kaijalainen S; Kyllönen L; Sordi V; Piemonti L; Roivainen M
J Med Virol; 2010 Nov; 82(11):1940-9. PubMed ID: 20872722
[TBL] [Abstract][Full Text] [Related]
16. Novel role for decay-accelerating factor in coxsackievirus A21-mediated cell infectivity.
Newcombe NG; Beagley LG; Christiansen D; Loveland BE; Johansson ES; Beagley KW; Barry RD; Shafren DR
J Virol; 2004 Nov; 78(22):12677-82. PubMed ID: 15507656
[TBL] [Abstract][Full Text] [Related]
17. More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
Jimenez-Clavero MA; Escribano-Romero E; Ley V; Spiller OB
J Gen Virol; 2005 May; 86(Pt 5):1369-1377. PubMed ID: 15831949
[TBL] [Abstract][Full Text] [Related]
18. A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts.
Stuart AD; Eustace HE; McKee TA; Brown TD
J Virol; 2002 Sep; 76(18):9307-22. PubMed ID: 12186914
[TBL] [Abstract][Full Text] [Related]
19. Mapping the binding domains on decay accelerating factor (DAF) for haemagglutinating enteroviruses: implications for the evolution of a DAF-binding phenotype.
Powell RM; Ward T; Goodfellow I; Almond JW; Evans DJ
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3145-3152. PubMed ID: 10567645
[TBL] [Abstract][Full Text] [Related]
20. Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line.
Riabi S; Harrath R; Gaaloul I; Bouslama L; Nasri D; Aouni M; Pillet S; Pozzetto B
J Biomed Sci; 2014 May; 21(1):50. PubMed ID: 24885774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
